VUGENE Funding News- Lithuanian Startup VUGENE Raises €1Mn In Funding

The investment was led by Superhero Capital, with support from NGL Ventures, Coinvest Capital, and several angel investors, according to a statement on VUGENE’s website.

Founded in 2021 by Juozas Gordevičius, VUGENE combines expertise in biology, data science, and computer science to transform health research.

Its platform connects data from different omics sources (like genomics and proteomics) and is quickly gaining attention from global academic and industry leaders, including Corewell Health, Barrow Neurological Institute, and RUSH University Medical Center.

“This investment serves as a confirmation that our brilliant, high-performing, and highly skilled multidisciplinary team is driving biomedical data science towards outstanding innovation. I’m truly excited that this investment will allow us to scale our innovation globally and empower our team to deliver the most accurate and comprehensive insights, helping R&D companies in the life science and biotech industries achieve their scientific discoveries,” Gražina Mykolaitytė, CEO and Co-Founder of VUGENE, comments.

The funding round was led by Superhero Capital, a Helsinki-based venture capital fund that invests up to €1 million in early-stage software startups in Finland and the Baltics.

Other investors included NGL Ventures, which focuses on life sciences, Coinvest Capital, and a group of angel investors.

“VUGENE is addressing a fundamental bottleneck in biomedical research by automating complex biological data interpretation. The startup’s strong commercial traction, exceptional team, and proprietary technology position them well to continue its growth and become a category leader in a rapidly growing market. We are excited to back VUGENE as they scale their product globally and help accelerate scientific discoveries across biotech and pharma,” Justinas Pašys, CEO of NGL Ventures, added.

The new funding will help VUGENE grow faster as a global service provider, turning complex biological data into useful insights.

VUGENE will use the money to expand its platform worldwide and support research in areas like neurodegeneration, cancer, gene therapy, and heart disease.

About VUGENE

VUGENE is a bioinformatics data science company based in Vilnius, Lithuania. They help research labs that study complex diseases by offering a variety of data analysis services. VUGENE specializes in working with multi-omics data and provides tools and support for tasks like quality checks, data processing, normalization, statistical analysis, and training machine learning models.